Analysis of p16 expression and allelic imbalance/loss of heterozygosity of 9p21 in cutaneous squamous cell carcinomas

Sarah E. Gray, Elaine Kay, Mary Leader, Mohamed Mabruk

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Deletions of the short arm of chromosome 9 have been reported in different types of malignancies. This chromosomal region contains a number of known tumour suppressor genes, including the p16INK4A (CDKN2A), p15 INK4B and MTAP tumour suppressor genes located at 9p21. In this study twenty-two paraffin embedded invasive cutaneous SCC were examined for allelic imbalance/loss of heterozygosity (AL/LOH) of the 9p region (in particular 9p21), and for p16 protein expression. DNA was isolated from microdissected sections of normal and tumour cells and analysed for AI/LOH by using six fluorescently labelled microsatellite markers that map to the 9p region. P16 protein expression was examined by immunohistochemistry. At each of the six microsatellite markers the majority of SCC analysed showed AI/LOH. Overall both AL/LOH within the CDKN2A locus and absence of p16 protein expression were frequent among the cutaneous SCC analysed, suggesting that p16 inactivation may play a role in cutaneous SCC development. The majority of the SCC analysed also had AI/LOH of the marker within the MTAP gene, and at markers flanking the CDKN2A gene; thus further investigation as to a possible role for these genes in the development of cutaneous SCC is warranted.

Original languageEnglish
Pages (from-to)778-788
Number of pages11
JournalJournal of Cellular and Molecular Medicine
Volume10
Issue number3
DOIs
Publication statusPublished - 2006

Fingerprint

Allelic Imbalance
Loss of Heterozygosity
Squamous Cell Carcinoma
Genes
Skin
Tumors
Tumor Suppressor Genes
Microsatellite Repeats
p16 Genes
Chromosomes, Human, Pair 9
Proteins
Paraffin
Neoplasms
Chromosomes
Immunohistochemistry
Cells
Epithelial Cells
DNA

Keywords

  • AI/LOH
  • Cutaneous SCC
  • MTAP
  • p15
  • p16

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Biochemistry

Cite this

Analysis of p16 expression and allelic imbalance/loss of heterozygosity of 9p21 in cutaneous squamous cell carcinomas. / Gray, Sarah E.; Kay, Elaine; Leader, Mary; Mabruk, Mohamed.

In: Journal of Cellular and Molecular Medicine, Vol. 10, No. 3, 2006, p. 778-788.

Research output: Contribution to journalArticle

@article{17a283cc30d54c108ce22935af82cf83,
title = "Analysis of p16 expression and allelic imbalance/loss of heterozygosity of 9p21 in cutaneous squamous cell carcinomas",
abstract = "Deletions of the short arm of chromosome 9 have been reported in different types of malignancies. This chromosomal region contains a number of known tumour suppressor genes, including the p16INK4A (CDKN2A), p15 INK4B and MTAP tumour suppressor genes located at 9p21. In this study twenty-two paraffin embedded invasive cutaneous SCC were examined for allelic imbalance/loss of heterozygosity (AL/LOH) of the 9p region (in particular 9p21), and for p16 protein expression. DNA was isolated from microdissected sections of normal and tumour cells and analysed for AI/LOH by using six fluorescently labelled microsatellite markers that map to the 9p region. P16 protein expression was examined by immunohistochemistry. At each of the six microsatellite markers the majority of SCC analysed showed AI/LOH. Overall both AL/LOH within the CDKN2A locus and absence of p16 protein expression were frequent among the cutaneous SCC analysed, suggesting that p16 inactivation may play a role in cutaneous SCC development. The majority of the SCC analysed also had AI/LOH of the marker within the MTAP gene, and at markers flanking the CDKN2A gene; thus further investigation as to a possible role for these genes in the development of cutaneous SCC is warranted.",
keywords = "AI/LOH, Cutaneous SCC, MTAP, p15, p16",
author = "Gray, {Sarah E.} and Elaine Kay and Mary Leader and Mohamed Mabruk",
year = "2006",
doi = "10.1111/j.1582-4934.2006.tb00437.x",
language = "English",
volume = "10",
pages = "778--788",
journal = "Journal of Cellular and Molecular Medicine",
issn = "1582-1838",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Analysis of p16 expression and allelic imbalance/loss of heterozygosity of 9p21 in cutaneous squamous cell carcinomas

AU - Gray, Sarah E.

AU - Kay, Elaine

AU - Leader, Mary

AU - Mabruk, Mohamed

PY - 2006

Y1 - 2006

N2 - Deletions of the short arm of chromosome 9 have been reported in different types of malignancies. This chromosomal region contains a number of known tumour suppressor genes, including the p16INK4A (CDKN2A), p15 INK4B and MTAP tumour suppressor genes located at 9p21. In this study twenty-two paraffin embedded invasive cutaneous SCC were examined for allelic imbalance/loss of heterozygosity (AL/LOH) of the 9p region (in particular 9p21), and for p16 protein expression. DNA was isolated from microdissected sections of normal and tumour cells and analysed for AI/LOH by using six fluorescently labelled microsatellite markers that map to the 9p region. P16 protein expression was examined by immunohistochemistry. At each of the six microsatellite markers the majority of SCC analysed showed AI/LOH. Overall both AL/LOH within the CDKN2A locus and absence of p16 protein expression were frequent among the cutaneous SCC analysed, suggesting that p16 inactivation may play a role in cutaneous SCC development. The majority of the SCC analysed also had AI/LOH of the marker within the MTAP gene, and at markers flanking the CDKN2A gene; thus further investigation as to a possible role for these genes in the development of cutaneous SCC is warranted.

AB - Deletions of the short arm of chromosome 9 have been reported in different types of malignancies. This chromosomal region contains a number of known tumour suppressor genes, including the p16INK4A (CDKN2A), p15 INK4B and MTAP tumour suppressor genes located at 9p21. In this study twenty-two paraffin embedded invasive cutaneous SCC were examined for allelic imbalance/loss of heterozygosity (AL/LOH) of the 9p region (in particular 9p21), and for p16 protein expression. DNA was isolated from microdissected sections of normal and tumour cells and analysed for AI/LOH by using six fluorescently labelled microsatellite markers that map to the 9p region. P16 protein expression was examined by immunohistochemistry. At each of the six microsatellite markers the majority of SCC analysed showed AI/LOH. Overall both AL/LOH within the CDKN2A locus and absence of p16 protein expression were frequent among the cutaneous SCC analysed, suggesting that p16 inactivation may play a role in cutaneous SCC development. The majority of the SCC analysed also had AI/LOH of the marker within the MTAP gene, and at markers flanking the CDKN2A gene; thus further investigation as to a possible role for these genes in the development of cutaneous SCC is warranted.

KW - AI/LOH

KW - Cutaneous SCC

KW - MTAP

KW - p15

KW - p16

UR - http://www.scopus.com/inward/record.url?scp=33845340822&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33845340822&partnerID=8YFLogxK

U2 - 10.1111/j.1582-4934.2006.tb00437.x

DO - 10.1111/j.1582-4934.2006.tb00437.x

M3 - Article

C2 - 16989737

AN - SCOPUS:33845340822

VL - 10

SP - 778

EP - 788

JO - Journal of Cellular and Molecular Medicine

JF - Journal of Cellular and Molecular Medicine

SN - 1582-1838

IS - 3

ER -